facebook
twitter
rss
account
search
search

Bayer to test antibiotic on TB

Oct. 19, 2005 at 3:06 AM   |   Comments

NEW YORK, Oct. 19 (UPI) -- The German pharmaceutical company Bayer HealthCare plans tests to determine if its newest antibiotic is effective against tuberculosis.

The New York Times said that no new drugs against tuberculosis have been registered in 40 years. Most drug companies do not test patented pharmaceuticals against diseases associated with poverty.

Bayer said that if moxifloxacin shortens TB treatment it will provide millions of doses for poor countries.

The trials are being funded by the Bill and Melinda Gates Foundation and by the Centers for Disease Control and Prevention, the new European and Developing Countries Clinical Trials Partnership and the Food and Drug Administration.

© 2005 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Army receives first advanced CH-47F helicopter variant
2
Auto sales grow 11% in July, Chrysler sales surge 20%
3
Excalibur IB artillery projective enters full-rate production
4
Austrian student files class action suit against Facebook
5
'No U.S. ban' on Iraqi oil, spokeswoman says
Trending News
Video
x
Feedback